Have symptoms of pulmonary sarcoidosis despite treatment
Taking 5-40 mg of prednisone for pulmonary sarcoidosis
Be willing to inject study medication at home
Taking a stable dose of prednisone for 4 weeks
Have a diagnosis of pulmonary arterial hypertension
History of scleroderma, osteoporosis, congestive heart failure
History of peptic ulcer requiring treatment or GI bleed within past 24 weeks
Recent major surgery within past 24 weeks
Uncontrolled diabetes, hypertension

Must be 40-80 years of age
Have a diagnosis of IPF within the past 5 years
Unchanged dose of pirfenidone or nintedanib for at least 12 weeks if currently taking these medications
Respiratory exacerbation or hospitalization in the last 3 months
Taking both pirfenidone and nintedanib simultaneously in the past 12 weeks
Lung transplant anticipated during the study
Known history of liver cirrhosis
Active smoker or cessation in the past 12 weeks

Ages 21-70
Smoke 5 or more cigarettes per day
Must be willing to both switch to a different type of cigarette and try an electronic cigarette
No serious quit attempt or use of smoking cessation medication in the past 30 days
Meet diagnostic criteria for current or lifetime mental health condition
Women who are pregnant, nursing, or trying to become pregnant
Any known allergy to propylene glycol or vegetable glycerin
History of difficulty providing blood samples
Other member of the household currently participating in the study
Unstable or significant medical condition in the past 3 months

Admission to ICU with acute risk factors for Acute Respiratory Distress Syndrome (ARDS): Pneumonia, Aspiration, smoke inhalation, lung contusion, hypoxemia, intubation
shock
sepsis
pancreatitis
Vit. D deficiency
unable to take Vit D by mouth
blood Calcium levels > 10.2
known kidney stone in past 1 year
Do Not Rescusitate orders (DNR)
prisoner

40 years of age or older
Patient Group: Fibrotic lung disease with chronic cough symptoms or Idiopathic cough syndrome
Healthy Control Group: no cough (either chronic or acute)
Recent history of smoking (former smokers must be tobacco-free for at least 1 year)
History of (other) lung diseases
History of uncontrolled gastroesophageal reflux disease (GERD)
Use of exclusionary medications (i.e. steroids, ACE inhibitors, narcotics, cough suppressants)
History of uncontrolled post nasal drip

Age 40 or greater
Diagnosis of Idiiopathic Pulmonary Fibrosis (IPF) within the past 5 years
HIV or hepatitis B or C diagnosis
History of malignancy within the past 5 years
Acute IPF reoccurrence in the past 6 months
Lower respiratory tract infection in the past 4 weeks requiring antibiotics
History of lung volume reduction surgery or lung transplant

Cervical or Thoracic Spinal Cord Injury
Ages 18-75
ASIA A or B
Ventilator dependent
Cystic Fibrosis
COPD

6 years old and greater
Must have Cystic Fibrosis (CF)
Positive culture for MRSA at screening
FEV1 between 30-90%
Commit to 14 visits over 12 months
You may not have allergies to vancomycin
Abnormal liver or kidney function
Inability to tolerate inhaled products

diagnosis of pulmonary fibrosis
presence of stage I-III defined by GAP index
expected to receive a lung transplant in the next 12 months
known explanation for interstitial lung disease
ongoing treatment with Esbriet

Age 21 or older
Current tobacco user
Age less than 21

General population
Adult
Age below 18 years
Mentally impaired